Our Story
DTRA was formed in 2020 by over 70 founding members from pharmaceutical companies and their technology partners, initiated during the COVID-19 pandemic to adopt decentralized technologies and maintain clinical trials.
EIN: 38-3990485 · San Diego, CA
DTRA was formed in 2020 by over 70 founding members from pharmaceutical companies and their technology partners, initiated during the COVID-19 pandemic to adopt decentralized technologies and maintain clinical trials.
DTRA enables collaboration among stakeholders to accelerate the adoption of patient-focused decentralized clinical trials, making research participation accessible to everyone.
Donating to DTRA supports the advancement of decentralized clinical trials, enhancing patient access and experience while reducing barriers to participation in clinical studies.
Your contribution can make a significant difference. Support DTRA today by donating cryptocurrency or cash to help transform clinical research and improve patient outcomes worldwide.
Do you represent DTRA? Sign up and claim this page to customize it and gain access to our dashboard. Learn More.